The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial

Journal of Substance Abuse Treatment

Volumn 19, Issue 1, 2000, Pages 77-79

  Kampman, Kyle M ^a,b   Rukstalis, Margaret ^a,b   Pettinati, Helen ^a   Muller, Eric ^a   Acosta, Thalia ^a   Gariti, Peter ^a,b   Ehrman, Ron ^a,b   O'Brien, Charles P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DRUG THERAPY, COMBINATION; FEMALE; FENFLURAMINE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; PHENTERMINE; PILOT PROJECTS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0034098403     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(99)00076-8     Document Type: Article

References (24)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;Author, Washington, DC.
2. Ayestas M.A., Baumann M.H., Rothman R.B. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens. NIDA Research Monograph. 153:1995;404.
3. Beck A.T., Beamsderfer A. Assessment of depression. the depression inventory Modern Problems of Pharmacopsychiatry. 7:1974;151-169.
4. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety. psychometric properties Journal of Consulting and Clinical Psychology. 56:1988;893-897.
5. Caroll M.E., Lac S.T., Asencio M., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacology Biochemistry and Behavior. 35:1990;237-244.
6. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., Schaff H.S. Valvular heart disease associated with fenfluramine-phentermine. The New England Journal of Medicine. 337:1997;581-588.
7. Giannini A.J., Baumgartel P., DiMarzio L.R. Bromocriptine therapy in cocaine withdrawal. Journal of Clinical Pharmacology. 27:1987;267-270.
8. Glowa J.R., Rice K.C., Matecka D., Rothman R.B. Phentermine/fenfluramine decrease cocaine self-administration in rhesus monkeys. NeuroReport. 8:1997;1347-1351.
9. Higgins G.A., Tompson D.M., Fletcher P.J., Sellers E.M. Effects of drugs influencing 5-HT function on ethanol drinking and feeding behavior in rats. studies using a drinkometer system Neuroscience Biobehavior Review. 16:1992;535-552.
10. Hitzig P. Combined dopamine and serotonin agonists. A synergistic approach to alcoholism and other addictive behaviors Maryland Medical Journal. 42:1993;153-157.
11. Kampman K., Volpicelli J.R., Alterman A.I., Cornish J., Weinrieb R., Epperson L., Sparkman T., O'Brien C.P. Amantadine in the early treatment of cocaine dependence. a double-blind, placebo-controlled trial Drug and Alcohol Dependence. 41:1996;25-33.
12. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addictive Behaviors. 23:1998;449-461.
13. Koob G.F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways Trends in Pharmacological Sciences. 13:1992;177-184.
14. Loh E.A., Roberts D.C.S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increased following depletion of forebrain serotonin. Psychopharmacology. 101:1990;262-266.
15. McGregor A., Lacosta S., Roberts D.C.S. L-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacology, Biochemistry and Behavior. 44:1993;651-655.
16. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 9:1992;199-213.
17. Richardson N.R., Roberts D.C.S. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sciences. 49:1991;833-840.
18. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
19. Rothman R.B., Gendron T., Hitzig P. Letter to the editor. Journal of Substance Abuse Treatment. 11:1994;273-275.
20. Schlaeper T.E., Pearlson G.D., Wong D.F., Marenco S., Dannals R.F. PET study of competition between intravenous cocaine and (11c) raclopride at dopamine receptors in human subjects. American Journal of Psychiatry. 154:1997;1209-1213.
21. Tennant F.S., Sagherian A.A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine. Archives of Internal Medicine. 147:1987;109-112.
22. Walsh S.L., Cunningham K.A. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology. 130:1997;41-58.
23. Walsh S.L., Preston K.L., Sullivan J.T., Fromme R., Bigelow G.E. Fluoxetine alters the effects of intravenous cocaine in humans. Journal of Clinical Psychopharmacology. 14:1994;396-407.
24. Wise R.A. Neural mechanisms of the reinforcing action of cocaine. NIDA Research Monograph. 50:1984;15-30.